Combination peroxisome proliferator-activated receptor γ and α agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content

R. Balasubramanian, J. Gerrard, C. Dalla Man, M. J. Firbank, A. Lane, P. T. English, C. Cobelli and R. Taylor

Diabetic Medicine 27 ( 2 ): 150 - 156 , 2010